

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 5.58648513 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.41152594 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.17562173 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 5.17562173 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.12820260 |
| 6 | respiratory electron transport chain (GO:0022904) | 4.35401721 |
| 7 | electron transport chain (GO:0022900) | 4.27168988 |
| 8 | GDP-mannose metabolic process (GO:0019673) | 4.17651505 |
| 9 | COPI coating of Golgi vesicle (GO:0048205) | 4.17496882 |
| 10 | Golgi transport vesicle coating (GO:0048200) | 4.17496882 |
| 11 | protein complex biogenesis (GO:0070271) | 4.13917428 |
| 12 | GTP biosynthetic process (GO:0006183) | 4.10285774 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.04133246 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.98238906 |
| 15 | cotranslational protein targeting to membrane (GO:0006613) | 3.97216514 |
| 16 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.91944180 |
| 17 | protein targeting to ER (GO:0045047) | 3.90024405 |
| 18 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.80647918 |
| 19 | protein localization to endoplasmic reticulum (GO:0070972) | 3.77839149 |
| 20 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.75477944 |
| 21 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.75477944 |
| 22 | NADH dehydrogenase complex assembly (GO:0010257) | 3.75477944 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.72153104 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.71795154 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.70756201 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.70756201 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.70756201 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.70756201 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.70756201 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.70756201 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.70277255 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.63155868 |
| 33 | negative regulation of cell killing (GO:0031342) | 3.63155868 |
| 34 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.60645694 |
| 35 | ribosomal small subunit assembly (GO:0000028) | 3.60586295 |
| 36 | fatty acid elongation (GO:0030497) | 3.59882782 |
| 37 | protein maturation by protein folding (GO:0022417) | 3.54349451 |
| 38 | ER overload response (GO:0006983) | 3.48401507 |
| 39 | mannosylation (GO:0097502) | 3.45315218 |
| 40 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.42102176 |
| 41 | nucleotide transmembrane transport (GO:1901679) | 3.39624607 |
| 42 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.37380594 |
| 43 | chaperone-mediated protein transport (GO:0072321) | 3.35799169 |
| 44 | protein neddylation (GO:0045116) | 3.33345524 |
| 45 | respiratory chain complex IV assembly (GO:0008535) | 3.32307461 |
| 46 | peptidyl-histidine modification (GO:0018202) | 3.31753755 |
| 47 | mannose metabolic process (GO:0006013) | 3.28275802 |
| 48 | response to peptidoglycan (GO:0032494) | 3.22248763 |
| 49 | ribosomal small subunit biogenesis (GO:0042274) | 3.20947896 |
| 50 | UTP biosynthetic process (GO:0006228) | 3.20501512 |
| 51 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.17928478 |
| 52 | response to redox state (GO:0051775) | 3.16769301 |
| 53 | proteasome assembly (GO:0043248) | 3.15812125 |
| 54 | cytochrome complex assembly (GO:0017004) | 3.12964663 |
| 55 | detection of bacterium (GO:0016045) | 3.12746623 |
| 56 | detection of other organism (GO:0098543) | 3.11288921 |
| 57 | pinocytosis (GO:0006907) | 3.09888357 |
| 58 | GPI anchor biosynthetic process (GO:0006506) | 3.09178917 |
| 59 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.02008635 |
| 60 | termination of RNA polymerase III transcription (GO:0006386) | 3.02008635 |
| 61 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.01918320 |
| 62 | viral transcription (GO:0019083) | 3.00001485 |
| 63 | stress fiber assembly (GO:0043149) | 2.99943653 |
| 64 | regulation of early endosome to late endosome transport (GO:2000641) | 2.98890748 |
| 65 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.98233228 |
| 66 | response to laminar fluid shear stress (GO:0034616) | 2.96995110 |
| 67 | CTP metabolic process (GO:0046036) | 2.95894301 |
| 68 | CTP biosynthetic process (GO:0006241) | 2.95894301 |
| 69 | protein localization to endosome (GO:0036010) | 2.94565826 |
| 70 | regulation of neuron projection regeneration (GO:0070570) | 2.91515577 |
| 71 | regulation of axon regeneration (GO:0048679) | 2.91515577 |
| 72 | barbed-end actin filament capping (GO:0051016) | 2.91313336 |
| 73 | hydrogen ion transmembrane transport (GO:1902600) | 2.88950983 |
| 74 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.88812838 |
| 75 | protein retention in ER lumen (GO:0006621) | 2.88025255 |
| 76 | regulation of extracellular matrix disassembly (GO:0010715) | 2.85719151 |
| 77 | detection of external biotic stimulus (GO:0098581) | 2.82705267 |
| 78 | translational termination (GO:0006415) | 2.82240812 |
| 79 | UTP metabolic process (GO:0046051) | 2.78788700 |
| 80 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.76942458 |
| 81 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.76942458 |
| 82 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.75716545 |
| 83 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.75301823 |
| 84 | regulation of gamma-delta T cell activation (GO:0046643) | 2.74310697 |
| 85 | autophagic vacuole fusion (GO:0000046) | 2.74004856 |
| 86 | GPI anchor metabolic process (GO:0006505) | 2.73518741 |
| 87 | regulation of oxidative phosphorylation (GO:0002082) | 2.73058589 |
| 88 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.73039118 |
| 89 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.72745760 |
| 90 | NIK/NF-kappaB signaling (GO:0038061) | 2.72324459 |
| 91 | macrophage activation involved in immune response (GO:0002281) | 2.71815979 |
| 92 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.70237783 |
| 93 | proton transport (GO:0015992) | 2.70201370 |
| 94 | detection of molecule of bacterial origin (GO:0032490) | 2.69806021 |
| 95 | response to muramyl dipeptide (GO:0032495) | 2.68244734 |
| 96 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.67274717 |
| 97 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.65860591 |
| 98 | hydrogen transport (GO:0006818) | 2.63588187 |
| 99 | aldehyde catabolic process (GO:0046185) | 2.63049104 |
| 100 | protein targeting to membrane (GO:0006612) | 2.62147795 |
| 101 | phagosome maturation (GO:0090382) | 2.61202293 |
| 102 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.60151310 |
| 103 | regulation of mitochondrial translation (GO:0070129) | 2.59702389 |
| 104 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58341749 |
| 105 | amino acid salvage (GO:0043102) | 2.58273575 |
| 106 | L-methionine salvage (GO:0071267) | 2.58273575 |
| 107 | L-methionine biosynthetic process (GO:0071265) | 2.58273575 |
| 108 | modulation by symbiont of host cellular process (GO:0044068) | 2.57767097 |
| 109 | peptide hormone processing (GO:0016486) | 2.57692264 |
| 110 | germinal center formation (GO:0002467) | 2.57356755 |
| 111 | regulation of leukocyte degranulation (GO:0043300) | 2.55892877 |
| 112 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.55833515 |
| 113 | positive regulation of extracellular matrix organization (GO:1903055) | 2.55385613 |
| 114 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.54965522 |
| 115 | central nervous system myelination (GO:0022010) | 2.54149329 |
| 116 | axon ensheathment in central nervous system (GO:0032291) | 2.54149329 |
| 117 | regulation of mast cell degranulation (GO:0043304) | 2.53988758 |
| 118 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.53371672 |
| 119 | regulation of metalloenzyme activity (GO:0048552) | 2.53057394 |
| 120 | intracellular protein transmembrane import (GO:0044743) | 2.52692566 |
| 121 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.52649481 |
| 122 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.52398630 |
| 123 | response to type I interferon (GO:0034340) | 2.51849289 |
| 124 | regulation of necroptotic process (GO:0060544) | 2.51765823 |
| 125 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.51714345 |
| 126 | response to host (GO:0075136) | 2.51714345 |
| 127 | response to host defenses (GO:0052200) | 2.51714345 |
| 128 | type I interferon signaling pathway (GO:0060337) | 2.51369548 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.51369548 |
| 130 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.51240861 |
| 131 | skin morphogenesis (GO:0043589) | 2.50058554 |
| 132 | translation (GO:0006412) | 2.48555237 |
| 133 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48075602 |
| 134 | L-phenylalanine catabolic process (GO:0006559) | 2.46219773 |
| 135 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.46219773 |
| 136 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.46005410 |
| 137 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.45349790 |
| 138 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.45294920 |
| 139 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.45282219 |
| 140 | intracellular pH reduction (GO:0051452) | 2.44870261 |
| 141 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.44661490 |
| 142 | signal complex assembly (GO:0007172) | 2.44629588 |
| 143 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.44207544 |
| 144 | embryonic process involved in female pregnancy (GO:0060136) | 2.43476036 |
| 145 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.42120270 |
| 146 | negative regulation of acute inflammatory response (GO:0002674) | 2.41916638 |
| 147 | cholesterol biosynthetic process (GO:0006695) | 2.41749662 |
| 148 | pH reduction (GO:0045851) | 2.40875710 |
| 149 | response to host immune response (GO:0052572) | 2.40215725 |
| 150 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.40215725 |
| 151 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.40102504 |
| 152 | protein targeting to mitochondrion (GO:0006626) | 2.40024649 |
| 153 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.40018659 |
| 154 | detection of biotic stimulus (GO:0009595) | 2.39722727 |
| 155 | dopamine transport (GO:0015872) | 2.38920347 |
| 156 | modulation by virus of host process (GO:0019054) | 2.38716197 |
| 157 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.38492726 |
| 158 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.38193153 |
| 159 | COPII vesicle coating (GO:0048208) | 2.37729895 |
| 160 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.37678607 |
| 161 | immunoglobulin mediated immune response (GO:0016064) | 2.37624008 |
| 162 | neutrophil activation involved in immune response (GO:0002283) | 2.37305961 |
| 163 | negative regulation of necroptotic process (GO:0060546) | 2.35281083 |
| 164 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.35026760 |
| 165 | fibril organization (GO:0097435) | 2.34893064 |
| 166 | basement membrane organization (GO:0071711) | 2.34657973 |
| 167 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.32460432 |
| 168 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.31693636 |
| 169 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.30794538 |
| 170 | ATP biosynthetic process (GO:0006754) | 2.30224071 |
| 171 | nucleotide transport (GO:0006862) | 2.30099763 |
| 172 | nucleoside diphosphate catabolic process (GO:0009134) | 2.29987775 |
| 173 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.29970685 |
| 174 | negative regulation of JUN kinase activity (GO:0043508) | 2.29963118 |
| 175 | negative regulation of viral release from host cell (GO:1902187) | 2.29938146 |
| 176 | leukocyte aggregation (GO:0070486) | 2.29708658 |
| 177 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.28961115 |
| 178 | positive regulation of receptor recycling (GO:0001921) | 2.28860159 |
| 179 | endocrine pancreas development (GO:0031018) | 2.28570519 |
| 180 | proline biosynthetic process (GO:0006561) | 2.28084689 |
| 181 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.27673856 |
| 182 | negative regulation of interleukin-12 production (GO:0032695) | 2.27443795 |
| 183 | positive regulation of nuclease activity (GO:0032075) | 2.27152503 |
| 184 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.26416012 |
| 185 | regulation of necrotic cell death (GO:0010939) | 2.25241685 |
| 186 | negative regulation of stress fiber assembly (GO:0051497) | 2.23902631 |
| 187 | pentose-phosphate shunt (GO:0006098) | 2.22164837 |
| 188 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.21881203 |
| 189 | myeloid dendritic cell differentiation (GO:0043011) | 2.21359745 |
| 190 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.20469634 |
| 191 | cellular extravasation (GO:0045123) | 2.20128249 |
| 192 | regulation of superoxide anion generation (GO:0032928) | 2.19015036 |
| 193 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.18745463 |
| 194 | negative regulation of innate immune response (GO:0045824) | 2.18601258 |
| 195 | peptidyl-proline hydroxylation (GO:0019511) | 2.18532773 |
| 196 | vesicle coating (GO:0006901) | 2.18283193 |
| 197 | hypotonic response (GO:0006971) | 2.17869302 |
| 198 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.17452711 |
| 199 | regulation of T cell tolerance induction (GO:0002664) | 2.16653762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.89969771 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.17975993 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.00180429 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.67862759 |
| 5 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.40539005 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.21910102 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.86585254 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.81224040 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.77992571 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.72049615 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.70072478 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.67825733 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.66134279 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.57065694 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.54186598 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.46953167 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46470578 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.45382332 |
| 19 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.41908902 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.36960041 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.32893053 |
| 22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.23274488 |
| 23 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.22203673 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.14364692 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.10768190 |
| 26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.09434715 |
| 27 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.00677329 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99592309 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95784786 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95766108 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93966482 |
| 32 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.93589258 |
| 33 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.90768063 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.87582227 |
| 35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87239672 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.85633026 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81767809 |
| 38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.81573847 |
| 39 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.79732657 |
| 40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.75496031 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.74608763 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74328765 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74161361 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.72903176 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72203442 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65832857 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65119123 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63965931 |
| 49 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63843182 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61890240 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61128327 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61094098 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61003541 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60864354 |
| 55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.56400169 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54959227 |
| 57 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.54515793 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54221093 |
| 59 | MAF_26560356_Chip-Seq_TH2_Human | 1.52596766 |
| 60 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52139300 |
| 61 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51967113 |
| 62 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.51511315 |
| 63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50623897 |
| 64 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.50102051 |
| 65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.48642049 |
| 66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48274082 |
| 67 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.47177764 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44616147 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.43807863 |
| 70 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.43511721 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42852427 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42501749 |
| 73 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.42321623 |
| 74 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41248640 |
| 75 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.40711004 |
| 76 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.38388222 |
| 77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37923257 |
| 78 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37846573 |
| 79 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37794658 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35737398 |
| 81 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.35369351 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34827280 |
| 83 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.34577668 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34110418 |
| 85 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.33769436 |
| 86 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.33618977 |
| 87 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.33385471 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.33373612 |
| 89 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.32795687 |
| 90 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.32282978 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27893102 |
| 92 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27726425 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27403903 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27007538 |
| 95 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.26374897 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25880593 |
| 97 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.24285130 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23783340 |
| 99 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23438911 |
| 100 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22546799 |
| 101 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22381375 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21546993 |
| 103 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20386561 |
| 104 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18370592 |
| 105 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.17900144 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 1.15698813 |
| 107 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.15592965 |
| 108 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.14993197 |
| 109 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.14357822 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14248476 |
| 111 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.13452135 |
| 112 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13089117 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13003985 |
| 114 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12812123 |
| 115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11969160 |
| 116 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11626900 |
| 117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11607389 |
| 118 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11498060 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11112556 |
| 120 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10950349 |
| 121 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10604542 |
| 122 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10537906 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10292206 |
| 124 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09893744 |
| 125 | P68_20966046_ChIP-Seq_HELA_Human | 1.09357445 |
| 126 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08764935 |
| 127 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08090421 |
| 128 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07496399 |
| 129 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06942352 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05177628 |
| 131 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05124467 |
| 132 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04142776 |
| 133 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03704060 |
| 134 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02799528 |
| 135 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02266823 |
| 136 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02231365 |
| 137 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02193747 |
| 138 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02135347 |
| 139 | MYB_26560356_Chip-Seq_TH2_Human | 1.01917384 |
| 140 | P300_19829295_ChIP-Seq_ESCs_Human | 1.00522379 |
| 141 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99964779 |
| 142 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99963992 |
| 143 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99742293 |
| 144 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.99582902 |
| 145 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99492381 |
| 146 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99482227 |
| 147 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99096991 |
| 148 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99042395 |
| 149 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97309838 |
| 150 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96530975 |
| 151 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.95714415 |
| 152 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.95230679 |
| 153 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94976970 |
| 154 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.94396773 |
| 155 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.94168585 |
| 156 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93406266 |
| 157 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91469875 |
| 158 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.91380633 |
| 159 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.89783158 |
| 160 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89489809 |
| 161 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.88414389 |
| 162 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87919837 |
| 163 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.86097505 |
| 164 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.86042362 |
| 165 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.85989764 |
| 166 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85574912 |
| 167 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85574912 |
| 168 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.85333481 |
| 169 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83770070 |
| 170 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83082221 |
| 171 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.82397467 |
| 172 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.82260395 |
| 173 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.82053624 |
| 174 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81166345 |
| 175 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.81084536 |
| 176 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.80999002 |
| 177 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.80454726 |
| 178 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.79393874 |
| 179 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.79348061 |
| 180 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.78952962 |
| 181 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.78886339 |
| 182 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.78696105 |
| 183 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78439434 |
| 184 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.76629206 |
| 185 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75084868 |
| 186 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.74624518 |
| 187 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.74467098 |
| 188 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.74117048 |
| 189 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.73872958 |
| 190 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.73075591 |
| 191 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.73006471 |
| 192 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.72866737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 3.77961039 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.56288126 |
| 3 | MP0005379_endocrine/exocrine_gland_phen | 3.11885838 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.04439677 |
| 5 | MP0003136_yellow_coat_color | 3.03435541 |
| 6 | MP0005451_abnormal_body_composition | 2.90894552 |
| 7 | MP0003195_calcinosis | 2.90508556 |
| 8 | MP0003303_peritoneal_inflammation | 2.81997689 |
| 9 | MP0010386_abnormal_urinary_bladder | 2.81886764 |
| 10 | MP0003880_abnormal_central_pattern | 2.80479722 |
| 11 | MP0009697_abnormal_copulation | 2.62888053 |
| 12 | MP0000013_abnormal_adipose_tissue | 2.61449815 |
| 13 | MP0008260_abnormal_autophagy | 2.51060002 |
| 14 | MP0009840_abnormal_foam_cell | 2.47571214 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.35394087 |
| 16 | MP0001905_abnormal_dopamine_level | 2.28140893 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.27745792 |
| 18 | MP0003566_abnormal_cell_adhesion | 2.21787956 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.18351757 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.10679257 |
| 21 | MP0002163_abnormal_gland_morphology | 2.09971827 |
| 22 | MP0005409_darkened_coat_color | 2.05422906 |
| 23 | MP0003186_abnormal_redox_activity | 2.01816927 |
| 24 | MP0000678_abnormal_parathyroid_gland | 1.99837759 |
| 25 | MP0002693_abnormal_pancreas_physiology | 1.89020717 |
| 26 | MP0003279_aneurysm | 1.86661650 |
| 27 | MP0000685_abnormal_immune_system | 1.84123504 |
| 28 | MP0004947_skin_inflammation | 1.82890720 |
| 29 | MP0005084_abnormal_gallbladder_morpholo | 1.80862531 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.79827858 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.79520948 |
| 32 | MP0008875_abnormal_xenobiotic_pharmacok | 1.78900977 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.77330411 |
| 34 | MP0001764_abnormal_homeostasis | 1.76300419 |
| 35 | MP0000858_altered_metastatic_potential | 1.75650390 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.75471720 |
| 37 | MP0001529_abnormal_vocalization | 1.73119370 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.72564465 |
| 39 | MP0003091_abnormal_cell_migration | 1.67139309 |
| 40 | MP0002735_abnormal_chemical_nociception | 1.67102457 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.65063652 |
| 42 | MP0005220_abnormal_exocrine_pancreas | 1.64611886 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.63735779 |
| 44 | MP0009278_abnormal_bone_marrow | 1.63583083 |
| 45 | MP0005171_absent_coat_pigmentation | 1.62275437 |
| 46 | MP0008004_abnormal_stomach_pH | 1.61265182 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.61107268 |
| 48 | MP0005275_abnormal_skin_tensile | 1.59702556 |
| 49 | MP0001958_emphysema | 1.59355660 |
| 50 | MP0001800_abnormal_humoral_immune | 1.53459727 |
| 51 | MP0000681_abnormal_thyroid_gland | 1.53009820 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.52966213 |
| 53 | MP0001944_abnormal_pancreas_morphology | 1.50099857 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.49771115 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 1.49172177 |
| 56 | MP0002132_abnormal_respiratory_system | 1.47148007 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.46895264 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.46778580 |
| 59 | MP0002295_abnormal_pulmonary_circulatio | 1.46492439 |
| 60 | MP0006292_abnormal_olfactory_placode | 1.45126785 |
| 61 | MP0002452_abnormal_antigen_presenting | 1.43986632 |
| 62 | MP0000372_irregular_coat_pigmentation | 1.43063229 |
| 63 | MP0005023_abnormal_wound_healing | 1.41493830 |
| 64 | MP0001849_ear_inflammation | 1.41271895 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.39712059 |
| 66 | MP0001819_abnormal_immune_cell | 1.39087076 |
| 67 | MP0002736_abnormal_nociception_after | 1.38295701 |
| 68 | MP0003724_increased_susceptibility_to | 1.37284157 |
| 69 | MP0004272_abnormal_basement_membrane | 1.37094121 |
| 70 | MP0004043_abnormal_pH_regulation | 1.37001959 |
| 71 | MP0009785_altered_susceptibility_to | 1.36889369 |
| 72 | MP0004858_abnormal_nervous_system | 1.33745285 |
| 73 | MP0001664_abnormal_digestion | 1.33236723 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 1.31410548 |
| 75 | MP0001968_abnormal_touch/_nociception | 1.30022021 |
| 76 | MP0001188_hyperpigmentation | 1.29552805 |
| 77 | MP0000920_abnormal_myelination | 1.28953709 |
| 78 | MP0005408_hypopigmentation | 1.28704019 |
| 79 | MP0006082_CNS_inflammation | 1.28256269 |
| 80 | MP0000015_abnormal_ear_pigmentation | 1.27366351 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 1.27300921 |
| 82 | MP0001545_abnormal_hematopoietic_system | 1.27124100 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 1.27124100 |
| 84 | MP0002405_respiratory_system_inflammati | 1.26757098 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 1.26724359 |
| 86 | MP0001835_abnormal_antigen_presentation | 1.25999369 |
| 87 | MP0005257_abnormal_intraocular_pressure | 1.25894103 |
| 88 | MP0005076_abnormal_cell_differentiation | 1.24371424 |
| 89 | MP0006276_abnormal_autonomic_nervous | 1.23774042 |
| 90 | MP0002398_abnormal_bone_marrow | 1.23220127 |
| 91 | MP0005360_urolithiasis | 1.21444696 |
| 92 | MP0003828_pulmonary_edema | 1.20403242 |
| 93 | MP0005671_abnormal_response_to | 1.20208201 |
| 94 | MP0004510_myositis | 1.17574439 |
| 95 | MP0001845_abnormal_inflammatory_respons | 1.17523238 |
| 96 | MP0005365_abnormal_bile_salt | 1.15960998 |
| 97 | MP0000613_abnormal_salivary_gland | 1.14583142 |
| 98 | MP0002139_abnormal_hepatobiliary_system | 1.13596042 |
| 99 | MP0002396_abnormal_hematopoietic_system | 1.13517793 |
| 100 | MP0000716_abnormal_immune_system | 1.12884171 |
| 101 | MP0002933_joint_inflammation | 1.12736662 |
| 102 | MP0001666_abnormal_nutrient_absorption | 1.12334745 |
| 103 | MP0004381_abnormal_hair_follicle | 1.11520061 |
| 104 | MP0001765_abnormal_ion_homeostasis | 1.11381231 |
| 105 | MP0003011_delayed_dark_adaptation | 1.10720673 |
| 106 | MP0002272_abnormal_nervous_system | 1.09017698 |
| 107 | MP0001542_abnormal_bone_strength | 1.08797477 |
| 108 | MP0002419_abnormal_innate_immunity | 1.07848424 |
| 109 | MP0004270_analgesia | 1.07178029 |
| 110 | MP0001853_heart_inflammation | 1.07043902 |
| 111 | MP0003075_altered_response_to | 1.06172022 |
| 112 | MP0001851_eye_inflammation | 1.06038150 |
| 113 | MP0005503_abnormal_tendon_morphology | 1.05784217 |
| 114 | MP0002734_abnormal_mechanical_nocicepti | 1.05432068 |
| 115 | MP0010234_abnormal_vibrissa_follicle | 1.04780482 |
| 116 | MP0002722_abnormal_immune_system | 1.04518651 |
| 117 | MP0005390_skeleton_phenotype | 1.03607852 |
| 118 | MP0002429_abnormal_blood_cell | 1.03019270 |
| 119 | MP0005025_abnormal_response_to | 1.02903729 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 1.02796277 |
| 121 | MP0005058_abnormal_lysosome_morphology | 1.01624744 |
| 122 | MP0003879_abnormal_hair_cell | 1.01115281 |
| 123 | MP0000343_altered_response_to | 0.99735475 |
| 124 | MP0002064_seizures | 0.98982371 |
| 125 | MP0002060_abnormal_skin_morphology | 0.98186383 |
| 126 | MP0004808_abnormal_hematopoietic_stem | 0.97932102 |
| 127 | MP0005000_abnormal_immune_tolerance | 0.97616953 |
| 128 | MP0002938_white_spotting | 0.97549219 |
| 129 | MP0004264_abnormal_extraembryonic_tissu | 0.97318003 |
| 130 | MP0000767_abnormal_smooth_muscle | 0.97262378 |
| 131 | MP0004883_abnormal_blood_vessel | 0.96058031 |
| 132 | MP0002909_abnormal_adrenal_gland | 0.95100695 |
| 133 | MP0003448_altered_tumor_morphology | 0.94840656 |
| 134 | MP0003656_abnormal_erythrocyte_physiolo | 0.94394772 |
| 135 | MP0000689_abnormal_spleen_morphology | 0.93655016 |
| 136 | MP0001501_abnormal_sleep_pattern | 0.93417750 |
| 137 | MP0003795_abnormal_bone_structure | 0.92443579 |
| 138 | MP0009745_abnormal_behavioral_response | 0.92129913 |
| 139 | MP0004142_abnormal_muscle_tone | 0.91899836 |
| 140 | MP0003868_abnormal_feces_composition | 0.91749548 |
| 141 | MP0001970_abnormal_pain_threshold | 0.91283118 |
| 142 | MP0000703_abnormal_thymus_morphology | 0.89960663 |
| 143 | MP0002877_abnormal_melanocyte_morpholog | 0.89774955 |
| 144 | MP0000538_abnormal_urinary_bladder | 0.89647854 |
| 145 | MP0005164_abnormal_response_to | 0.88400794 |
| 146 | MP0005387_immune_system_phenotype | 0.87428409 |
| 147 | MP0001790_abnormal_immune_system | 0.87428409 |
| 148 | MP0005621_abnormal_cell_physiology | 0.85973622 |
| 149 | MP0010352_gastrointestinal_tract_polyps | 0.85921178 |
| 150 | MP0000604_amyloidosis | 0.85795460 |
| 151 | MP0000490_abnormal_crypts_of | 0.85713755 |
| 152 | MP0002796_impaired_skin_barrier | 0.85534948 |
| 153 | MP0008469_abnormal_protein_level | 0.85271461 |
| 154 | MP0005166_decreased_susceptibility_to | 0.83580771 |
| 155 | MP0001915_intracranial_hemorrhage | 0.82361597 |
| 156 | MP0002078_abnormal_glucose_homeostasis | 0.81522807 |
| 157 | MP0005535_abnormal_body_temperature | 0.81422756 |
| 158 | MP0005645_abnormal_hypothalamus_physiol | 0.80164973 |
| 159 | MP0005381_digestive/alimentary_phenotyp | 0.79365400 |
| 160 | MP0005332_abnormal_amino_acid | 0.78714438 |
| 161 | MP0002572_abnormal_emotion/affect_behav | 0.78228841 |
| 162 | MP0000249_abnormal_blood_vessel | 0.77817066 |
| 163 | MP0003866_abnormal_defecation | 0.77747332 |
| 164 | MP0005646_abnormal_pituitary_gland | 0.77409790 |
| 165 | MP0001348_abnormal_lacrimal_gland | 0.77174922 |
| 166 | MP0001533_abnormal_skeleton_physiology | 0.76722763 |
| 167 | MP0009643_abnormal_urine_homeostasis | 0.76409695 |
| 168 | MP0000465_gastrointestinal_hemorrhage | 0.76183338 |
| 169 | MP0002723_abnormal_immune_serum | 0.75917901 |
| 170 | MP0000230_abnormal_systemic_arterial | 0.75627271 |
| 171 | MP0005310_abnormal_salivary_gland | 0.74243456 |
| 172 | MP0003436_decreased_susceptibility_to | 0.73810508 |
| 173 | MP0001502_abnormal_circadian_rhythm | 0.72564752 |
| 174 | MP0001663_abnormal_digestive_system | 0.71577780 |
| 175 | MP0003959_abnormal_lean_body | 0.70644378 |
| 176 | MP0002733_abnormal_thermal_nociception | 0.70588522 |
| 177 | MP0005083_abnormal_biliary_tract | 0.68601985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Renal Fanconi syndrome (HP:0001994) | 5.59004993 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.81015243 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.32954783 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.13997234 |
| 5 | Acute encephalopathy (HP:0006846) | 3.98560565 |
| 6 | Increased hepatocellular lipid droplets (HP:0006565) | 3.94319535 |
| 7 | 3-Methylglutaconic aciduria (HP:0003535) | 3.89726007 |
| 8 | Progressive macrocephaly (HP:0004481) | 3.87754384 |
| 9 | Protrusio acetabuli (HP:0003179) | 3.83038908 |
| 10 | Premature rupture of membranes (HP:0001788) | 3.82006387 |
| 11 | Abnormality of renal resorption (HP:0011038) | 3.64340186 |
| 12 | Lipid accumulation in hepatocytes (HP:0006561) | 3.59397925 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.57060751 |
| 14 | Increased CSF lactate (HP:0002490) | 3.47791230 |
| 15 | Hepatocellular necrosis (HP:0001404) | 3.29000994 |
| 16 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.23852897 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.17817339 |
| 18 | Hepatic necrosis (HP:0002605) | 3.17777399 |
| 19 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.17574951 |
| 20 | Symptomatic seizures (HP:0011145) | 3.17483248 |
| 21 | Hyperphosphaturia (HP:0003109) | 3.11745533 |
| 22 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.99034987 |
| 23 | Peritonitis (HP:0002586) | 2.96723472 |
| 24 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.92090632 |
| 25 | Parakeratosis (HP:0001036) | 2.89625693 |
| 26 | Generalized aminoaciduria (HP:0002909) | 2.82307320 |
| 27 | Vertebral compression fractures (HP:0002953) | 2.81248892 |
| 28 | Retinal dysplasia (HP:0007973) | 2.80588608 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 2.79441966 |
| 30 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.78445688 |
| 31 | Cerebral edema (HP:0002181) | 2.71865228 |
| 32 | Exertional dyspnea (HP:0002875) | 2.68898492 |
| 33 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.67827785 |
| 34 | Increased intramyocellular lipid droplets (HP:0012240) | 2.58355235 |
| 35 | Dilatation of the ascending aorta (HP:0005111) | 2.58294662 |
| 36 | Hyperparathyroidism (HP:0000843) | 2.57420665 |
| 37 | Aortic aneurysm (HP:0004942) | 2.56550117 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 2.51563223 |
| 39 | Abnormal urine phosphate concentration (HP:0012599) | 2.49822346 |
| 40 | Cellulitis (HP:0100658) | 2.49419999 |
| 41 | Prolonged partial thromboplastin time (HP:0003645) | 2.49106818 |
| 42 | Type I transferrin isoform profile (HP:0003642) | 2.46155936 |
| 43 | Cervical subluxation (HP:0003308) | 2.43220357 |
| 44 | Hemorrhage of the eye (HP:0011885) | 2.43136979 |
| 45 | Optic disc pallor (HP:0000543) | 2.41737301 |
| 46 | Dysostosis multiplex (HP:0000943) | 2.40786622 |
| 47 | Deep venous thrombosis (HP:0002625) | 2.40614467 |
| 48 | Polycythemia (HP:0001901) | 2.40519034 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.40032997 |
| 50 | Gingival bleeding (HP:0000225) | 2.39777373 |
| 51 | Gastrointestinal infarctions (HP:0005244) | 2.38499460 |
| 52 | Myositis (HP:0100614) | 2.38221337 |
| 53 | Aortic dissection (HP:0002647) | 2.35444674 |
| 54 | Exercise intolerance (HP:0003546) | 2.34994340 |
| 55 | Petechiae (HP:0000967) | 2.34985562 |
| 56 | Lactic acidosis (HP:0003128) | 2.34723400 |
| 57 | Epistaxis (HP:0000421) | 2.34610074 |
| 58 | Recurrent abscess formation (HP:0002722) | 2.34316352 |
| 59 | Increased IgE level (HP:0003212) | 2.31651816 |
| 60 | Cholecystitis (HP:0001082) | 2.31121608 |
| 61 | Abnormal gallbladder physiology (HP:0012438) | 2.31121608 |
| 62 | Hypothermia (HP:0002045) | 2.29965151 |
| 63 | Blue sclerae (HP:0000592) | 2.29914454 |
| 64 | Protuberant abdomen (HP:0001538) | 2.28263578 |
| 65 | Increased variability in muscle fiber diameter (HP:0003557) | 2.28175143 |
| 66 | Cerebral aneurysm (HP:0004944) | 2.27856426 |
| 67 | Orchitis (HP:0100796) | 2.25657930 |
| 68 | Recurrent bacterial skin infections (HP:0005406) | 2.25047370 |
| 69 | Renal tubular dysfunction (HP:0000124) | 2.24051892 |
| 70 | Glycosuria (HP:0003076) | 2.23757625 |
| 71 | Abnormality of urine glucose concentration (HP:0011016) | 2.23757625 |
| 72 | Abnormal protein glycosylation (HP:0012346) | 2.22176172 |
| 73 | Abnormal glycosylation (HP:0012345) | 2.22176172 |
| 74 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.22176172 |
| 75 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.22176172 |
| 76 | Respiratory failure (HP:0002878) | 2.21774224 |
| 77 | Osteomalacia (HP:0002749) | 2.19966883 |
| 78 | Leukodystrophy (HP:0002415) | 2.18994935 |
| 79 | Increased serum lactate (HP:0002151) | 2.18776190 |
| 80 | Colitis (HP:0002583) | 2.18345509 |
| 81 | Increased muscle lipid content (HP:0009058) | 2.17787126 |
| 82 | Spontaneous hematomas (HP:0007420) | 2.17597254 |
| 83 | Methylmalonic acidemia (HP:0002912) | 2.17268494 |
| 84 | Abnormality of dentin (HP:0010299) | 2.17172153 |
| 85 | Aneurysm (HP:0002617) | 2.17023396 |
| 86 | Type II lissencephaly (HP:0007260) | 2.16268128 |
| 87 | Increased connective tissue (HP:0009025) | 2.16003932 |
| 88 | Spondylolisthesis (HP:0003302) | 2.14375185 |
| 89 | Menorrhagia (HP:0000132) | 2.14049201 |
| 90 | Emphysema (HP:0002097) | 2.13769631 |
| 91 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.11864225 |
| 92 | Respiratory difficulties (HP:0002880) | 2.11585185 |
| 93 | Vascular tortuosity (HP:0004948) | 2.11259141 |
| 94 | Increased serum pyruvate (HP:0003542) | 2.11153291 |
| 95 | Abnormality of glycolysis (HP:0004366) | 2.11153291 |
| 96 | Chronic obstructive pulmonary disease (HP:0006510) | 2.10950782 |
| 97 | Obstructive lung disease (HP:0006536) | 2.10950782 |
| 98 | Disproportionate tall stature (HP:0001519) | 2.10061079 |
| 99 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.09574452 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 2.09461233 |
| 101 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.09202075 |
| 102 | Upper limb amyotrophy (HP:0009129) | 2.09189457 |
| 103 | Distal upper limb amyotrophy (HP:0007149) | 2.09189457 |
| 104 | Dysautonomia (HP:0002459) | 2.08869485 |
| 105 | Flat capital femoral epiphysis (HP:0003370) | 2.08598043 |
| 106 | Enlarged epiphyses (HP:0010580) | 2.07078129 |
| 107 | Proximal tubulopathy (HP:0000114) | 2.07046650 |
| 108 | Hypertensive crisis (HP:0100735) | 2.06613269 |
| 109 | Fragile skin (HP:0001030) | 2.06600449 |
| 110 | Mucopolysacchariduria (HP:0008155) | 2.06578213 |
| 111 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06578213 |
| 112 | Abnormality of the peritoneum (HP:0002585) | 2.05628374 |
| 113 | Delusions (HP:0000746) | 2.05311496 |
| 114 | Methylmalonic aciduria (HP:0012120) | 2.05150080 |
| 115 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.04653669 |
| 116 | Genu recurvatum (HP:0002816) | 2.04232019 |
| 117 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.03960906 |
| 118 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.03960906 |
| 119 | Conjugated hyperbilirubinemia (HP:0002908) | 2.03340722 |
| 120 | Metaphyseal irregularity (HP:0003025) | 2.03100283 |
| 121 | Irregular vertebral endplates (HP:0003301) | 2.02978137 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02347701 |
| 123 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02347701 |
| 124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02347701 |
| 125 | Achilles tendon contracture (HP:0001771) | 2.02334260 |
| 126 | Delayed epiphyseal ossification (HP:0002663) | 2.01738070 |
| 127 | Increased serum ferritin (HP:0003281) | 2.00587803 |
| 128 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.99389219 |
| 129 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.99389219 |
| 130 | Abnormality of glycolipid metabolism (HP:0010969) | 1.99389219 |
| 131 | Abnormality of complement system (HP:0005339) | 1.98753345 |
| 132 | Abnormality of the Achilles tendon (HP:0005109) | 1.97948373 |
| 133 | Gingivitis (HP:0000230) | 1.97469852 |
| 134 | Aplastic anemia (HP:0001915) | 1.96980866 |
| 135 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.96761102 |
| 136 | Irregular epiphyses (HP:0010582) | 1.96499463 |
| 137 | Abnormal platelet volume (HP:0011876) | 1.96045951 |
| 138 | Inflammation of the large intestine (HP:0002037) | 1.95062186 |
| 139 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.94881275 |
| 140 | Impaired platelet aggregation (HP:0003540) | 1.93683045 |
| 141 | Abnormal platelet function (HP:0011869) | 1.93683045 |
| 142 | Thin bony cortex (HP:0002753) | 1.93217100 |
| 143 | Arterial tortuosity (HP:0005116) | 1.92757299 |
| 144 | Myocardial infarction (HP:0001658) | 1.91875283 |
| 145 | Atrophic scars (HP:0001075) | 1.91072847 |
| 146 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.89550035 |
| 147 | Microvesicular hepatic steatosis (HP:0001414) | 1.88179320 |
| 148 | Cerebellar dysplasia (HP:0007033) | 1.87629315 |
| 149 | Loss of speech (HP:0002371) | 1.87138394 |
| 150 | Abnormality of the thoracic spine (HP:0100711) | 1.86998961 |
| 151 | Thoracic kyphosis (HP:0002942) | 1.86869045 |
| 152 | Amyloidosis (HP:0011034) | 1.86336529 |
| 153 | Hypomagnesemia (HP:0002917) | 1.85892637 |
| 154 | Abnormality of magnesium homeostasis (HP:0004921) | 1.85416960 |
| 155 | Mediastinal lymphadenopathy (HP:0100721) | 1.84692554 |
| 156 | Patchy hypopigmentation of hair (HP:0011365) | 1.83226152 |
| 157 | Gastrointestinal dysmotility (HP:0002579) | 1.82578772 |
| 158 | Abnormal number of erythroid precursors (HP:0012131) | 1.82542091 |
| 159 | Gastrointestinal stroma tumor (HP:0100723) | 1.82161610 |
| 160 | Wormian bones (HP:0002645) | 1.80030499 |
| 161 | Abnormality of the vertebral endplates (HP:0005106) | 1.79463914 |
| 162 | Spinal rigidity (HP:0003306) | 1.78676079 |
| 163 | Abnormal hemoglobin (HP:0011902) | 1.78391267 |
| 164 | Medial flaring of the eyebrow (HP:0010747) | 1.78157325 |
| 165 | Broad face (HP:0000283) | 1.77937981 |
| 166 | Fatigue (HP:0012378) | 1.77593292 |
| 167 | Recurrent fungal infections (HP:0002841) | 1.77347667 |
| 168 | Interstitial pulmonary disease (HP:0006530) | 1.75916494 |
| 169 | Brushfield spots (HP:0001088) | 1.75826960 |
| 170 | Glomerulonephritis (HP:0000099) | 1.75737712 |
| 171 | Recurrent viral infections (HP:0004429) | 1.75737521 |
| 172 | Long palpebral fissure (HP:0000637) | 1.75676819 |
| 173 | Hand muscle atrophy (HP:0009130) | 1.75338205 |
| 174 | Metaphyseal cupping (HP:0003021) | 1.74614062 |
| 175 | Neuroendocrine neoplasm (HP:0100634) | 1.74411831 |
| 176 | Hypertriglyceridemia (HP:0002155) | 1.74217138 |
| 177 | Distal lower limb amyotrophy (HP:0008944) | 1.73793485 |
| 178 | Obstructive sleep apnea (HP:0002870) | 1.72698744 |
| 179 | Vasculitis (HP:0002633) | 1.72306171 |
| 180 | Epiphyseal dysplasia (HP:0002656) | 1.71870892 |
| 181 | Slow saccadic eye movements (HP:0000514) | 1.71540084 |
| 182 | Biconcave vertebral bodies (HP:0004586) | 1.71286551 |
| 183 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.70034297 |
| 184 | Beaking of vertebral bodies (HP:0004568) | 1.69597666 |
| 185 | Lethargy (HP:0001254) | 1.68985001 |
| 186 | Metaphyseal dysplasia (HP:0100255) | 1.67902507 |
| 187 | Macrocytic anemia (HP:0001972) | 1.67703042 |
| 188 | Hypophosphatemia (HP:0002148) | 1.62351135 |
| 189 | Atelectasis (HP:0100750) | 1.61875707 |
| 190 | Abnormality of vitamin metabolism (HP:0100508) | 1.61059963 |
| 191 | Reduced antithrombin III activity (HP:0001976) | 1.60991119 |
| 192 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.60539931 |
| 193 | Hypoglycemic coma (HP:0001325) | 1.60163947 |
| 194 | Neurofibrillary tangles (HP:0002185) | 1.58910051 |
| 195 | Abnormal epiphyseal ossification (HP:0010656) | 1.57366451 |
| 196 | Purpura (HP:0000979) | 1.57184501 |
| 197 | White forelock (HP:0002211) | 1.56664183 |
| 198 | X-linked dominant inheritance (HP:0001423) | 1.55191346 |
| 199 | Abnormal ciliary motility (HP:0012262) | 1.54922829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.38120036 |
| 2 | PRPF4B | 3.71059394 |
| 3 | TRIB3 | 3.10826580 |
| 4 | STK16 | 2.98917611 |
| 5 | BCKDK | 2.70731013 |
| 6 | INSRR | 2.41170003 |
| 7 | CASK | 2.38276616 |
| 8 | MAPK15 | 2.34624737 |
| 9 | SIK1 | 2.27757649 |
| 10 | NME1 | 2.23002762 |
| 11 | MAP3K12 | 2.22125438 |
| 12 | SMG1 | 2.17396498 |
| 13 | MAP4K1 | 2.16193906 |
| 14 | ARAF | 2.13473135 |
| 15 | PIK3CG | 2.12412578 |
| 16 | TYK2 | 2.09274702 |
| 17 | BMPR2 | 2.01464405 |
| 18 | RIPK4 | 2.00833053 |
| 19 | FGFR4 | 1.98584134 |
| 20 | MAP2K3 | 1.95874849 |
| 21 | BMPR1B | 1.89082549 |
| 22 | EPHA3 | 1.88713266 |
| 23 | PBK | 1.88265505 |
| 24 | TNIK | 1.86148863 |
| 25 | MST4 | 1.73322025 |
| 26 | EPHA4 | 1.70950540 |
| 27 | RIPK1 | 1.69592630 |
| 28 | TLK1 | 1.68406731 |
| 29 | PIM2 | 1.68041582 |
| 30 | ICK | 1.65987425 |
| 31 | TAOK2 | 1.65724365 |
| 32 | TAOK3 | 1.64692085 |
| 33 | CDK12 | 1.55129193 |
| 34 | ZAP70 | 1.54107453 |
| 35 | CDK19 | 1.53676416 |
| 36 | ADRBK2 | 1.44542296 |
| 37 | MAP3K1 | 1.40633125 |
| 38 | KSR2 | 1.38972893 |
| 39 | IRAK1 | 1.38268189 |
| 40 | EEF2K | 1.37168931 |
| 41 | CDC42BPA | 1.37115439 |
| 42 | EIF2AK3 | 1.36975939 |
| 43 | MAP3K3 | 1.34509371 |
| 44 | PRKD2 | 1.31051000 |
| 45 | IRAK4 | 1.29051448 |
| 46 | PDGFRA | 1.27081583 |
| 47 | VRK1 | 1.26364323 |
| 48 | PKN2 | 1.26241149 |
| 49 | TAOK1 | 1.23871905 |
| 50 | BLK | 1.22201273 |
| 51 | IRAK3 | 1.21400598 |
| 52 | CSK | 1.20759225 |
| 53 | PIK3CA | 1.20278856 |
| 54 | PTK2B | 1.17217209 |
| 55 | OXSR1 | 1.17034747 |
| 56 | MAP2K7 | 1.16259024 |
| 57 | MAP3K10 | 1.13323729 |
| 58 | MAP3K14 | 1.13167253 |
| 59 | MYLK | 1.12024255 |
| 60 | MAP3K13 | 1.10689620 |
| 61 | MAP3K11 | 1.10561129 |
| 62 | TESK1 | 1.10386487 |
| 63 | FLT3 | 1.07943614 |
| 64 | BRAF | 1.05581267 |
| 65 | MUSK | 1.04710573 |
| 66 | NTRK1 | 1.02906340 |
| 67 | NLK | 0.99847416 |
| 68 | PAK4 | 0.99446290 |
| 69 | PTK6 | 0.99250456 |
| 70 | GRK7 | 0.98280353 |
| 71 | JAK1 | 0.97910270 |
| 72 | GRK5 | 0.97436517 |
| 73 | TXK | 0.96624684 |
| 74 | HIPK2 | 0.95693998 |
| 75 | BMX | 0.95653989 |
| 76 | DDR2 | 0.94168056 |
| 77 | SYK | 0.93970497 |
| 78 | MARK2 | 0.93613952 |
| 79 | PDPK1 | 0.90600423 |
| 80 | DYRK2 | 0.90349692 |
| 81 | MET | 0.89348343 |
| 82 | STK39 | 0.88139336 |
| 83 | LRRK2 | 0.86086104 |
| 84 | MAPKAPK5 | 0.83427227 |
| 85 | EPHA2 | 0.81995272 |
| 86 | TGFBR2 | 0.81654330 |
| 87 | HCK | 0.80686928 |
| 88 | TEC | 0.80195817 |
| 89 | STK38 | 0.80018593 |
| 90 | TNK2 | 0.79307454 |
| 91 | EPHB1 | 0.79240309 |
| 92 | MAPK11 | 0.78956592 |
| 93 | CAMK2B | 0.77735180 |
| 94 | NEK9 | 0.77451820 |
| 95 | PRKCE | 0.76283475 |
| 96 | FGFR3 | 0.75961240 |
| 97 | NTRK3 | 0.75241903 |
| 98 | DAPK3 | 0.74893025 |
| 99 | TTN | 0.74597230 |
| 100 | PRKG2 | 0.74203869 |
| 101 | AKT3 | 0.73757495 |
| 102 | GRK1 | 0.73567846 |
| 103 | MAPK13 | 0.73020401 |
| 104 | MAP3K6 | 0.72837649 |
| 105 | IKBKE | 0.72731199 |
| 106 | PTK2 | 0.72518408 |
| 107 | ERN1 | 0.72377657 |
| 108 | JAK3 | 0.71039588 |
| 109 | ABL2 | 0.70905471 |
| 110 | IRAK2 | 0.70492421 |
| 111 | JAK2 | 0.70450948 |
| 112 | BTK | 0.69490224 |
| 113 | MAP3K8 | 0.68735040 |
| 114 | PLK2 | 0.68188569 |
| 115 | IKBKB | 0.68101554 |
| 116 | CSF1R | 0.67040420 |
| 117 | CAMK2D | 0.66972496 |
| 118 | NEK6 | 0.66552578 |
| 119 | FGR | 0.66470717 |
| 120 | MTOR | 0.66421062 |
| 121 | MST1R | 0.66277712 |
| 122 | LYN | 0.65979997 |
| 123 | RET | 0.64939982 |
| 124 | MARK3 | 0.63689672 |
| 125 | PDK1 | 0.63213259 |
| 126 | LMTK2 | 0.63105348 |
| 127 | CAMK2A | 0.62152489 |
| 128 | SIK2 | 0.61983810 |
| 129 | MOS | 0.61613691 |
| 130 | WNK4 | 0.61028342 |
| 131 | STK10 | 0.60254087 |
| 132 | PKN1 | 0.59711986 |
| 133 | FES | 0.58926915 |
| 134 | MAP3K7 | 0.58016866 |
| 135 | MAP3K2 | 0.56106767 |
| 136 | MATK | 0.54617337 |
| 137 | MAPK12 | 0.52848606 |
| 138 | CLK1 | 0.52180776 |
| 139 | MAPK7 | 0.51517683 |
| 140 | MAPKAPK2 | 0.51394613 |
| 141 | TESK2 | 0.51228704 |
| 142 | ADRBK1 | 0.50836101 |
| 143 | SIK3 | 0.50645297 |
| 144 | RAF1 | 0.49866784 |
| 145 | TRPM7 | 0.48500123 |
| 146 | TBK1 | 0.48176769 |
| 147 | CAMKK2 | 0.47863426 |
| 148 | KIT | 0.47099137 |
| 149 | UHMK1 | 0.46860917 |
| 150 | RPS6KA2 | 0.46729879 |
| 151 | CDK8 | 0.45960623 |
| 152 | GRK6 | 0.45491459 |
| 153 | RPS6KA5 | 0.44669931 |
| 154 | CAMK2G | 0.44358490 |
| 155 | LCK | 0.44315430 |
| 156 | TIE1 | 0.43420310 |
| 157 | PDGFRB | 0.43162045 |
| 158 | PASK | 0.41846934 |
| 159 | MAP3K5 | 0.41782743 |
| 160 | BCR | 0.41553773 |
| 161 | RPS6KC1 | 0.41461446 |
| 162 | RPS6KL1 | 0.41461446 |
| 163 | DAPK1 | 0.40588764 |
| 164 | PRKCQ | 0.40164397 |
| 165 | PRKCD | 0.39277277 |
| 166 | ACVR1B | 0.37896058 |
| 167 | YES1 | 0.37460878 |
| 168 | ZAK | 0.36952302 |
| 169 | PRKACA | 0.36919699 |
| 170 | MAP2K2 | 0.35211995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 5.91976100 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.60350313 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.37697706 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.31883667 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.96486804 |
| 6 | Alzheimers disease_Homo sapiens_hsa05010 | 2.91342219 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.64002858 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.50128028 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.35076797 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.34156575 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.32290092 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.29099774 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.14670949 |
| 14 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.13836284 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06254080 |
| 16 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.04507722 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.03956137 |
| 18 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.98860154 |
| 19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.97367602 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.95988946 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.89799784 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.89478058 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.82158384 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75716510 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.69290304 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.64741557 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.62218970 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.59003047 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57325369 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56233347 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53090947 |
| 32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.44714219 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43923060 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.41789896 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.41599164 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.38447815 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37332152 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.36966885 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.34951027 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30843407 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.28191733 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.26267672 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.25705656 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.25269261 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.24922544 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.22877066 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22220801 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.21406666 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 1.19999857 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.19920574 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.18322017 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17995355 |
| 53 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.16766663 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 1.16424663 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.16202067 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16187119 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 1.16067381 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15440761 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 1.14670414 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.12608186 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11767762 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.11110132 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 1.10674996 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10637391 |
| 65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10251292 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 1.09724949 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07408284 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06207471 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 1.05560734 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05557578 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04970328 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04811716 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 1.01060808 |
| 74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00889824 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00573467 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.00337256 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00270219 |
| 78 | Focal adhesion_Homo sapiens_hsa04510 | 1.00080562 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.98094058 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97468520 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94620452 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93894770 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.93015974 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91580018 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.89086566 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88943645 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87965250 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.87298657 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86597513 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86482355 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86351009 |
| 92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85711293 |
| 93 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.85697811 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.85482556 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.83679877 |
| 96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81250419 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.80932975 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.80706831 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.80663637 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.80302880 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80033883 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78873821 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76589863 |
| 104 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76177992 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75550807 |
| 106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75410055 |
| 107 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73693699 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73314164 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72364447 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72121002 |
| 111 | Salmonella infection_Homo sapiens_hsa05132 | 0.72094737 |
| 112 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.71518561 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.71137097 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71007874 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70172371 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69808740 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.69079978 |
| 118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69013042 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68960181 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.68661820 |
| 121 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.68257085 |
| 122 | Taste transduction_Homo sapiens_hsa04742 | 0.68214198 |
| 123 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66635251 |
| 124 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65965840 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65878463 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65785870 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65254748 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64827790 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63836840 |
| 130 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63546794 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62927319 |
| 132 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62710092 |
| 133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62529465 |
| 134 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62447862 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61560462 |
| 136 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60900546 |
| 137 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60268765 |
| 138 | Purine metabolism_Homo sapiens_hsa00230 | 0.60139187 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59715452 |
| 140 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59649488 |
| 141 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58193175 |
| 142 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56762307 |
| 143 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56197817 |
| 144 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55499430 |
| 145 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55305825 |
| 146 | GABAergic synapse_Homo sapiens_hsa04727 | 0.53772135 |
| 147 | Glioma_Homo sapiens_hsa05214 | 0.53491624 |
| 148 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51504410 |
| 149 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50881124 |
| 150 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50581840 |
| 151 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.49876189 |
| 152 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48040072 |
| 153 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47838645 |
| 154 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47706960 |
| 155 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46117321 |
| 156 | Nicotine addiction_Homo sapiens_hsa05033 | 0.45414158 |
| 157 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42522682 |
| 158 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42141749 |
| 159 | Morphine addiction_Homo sapiens_hsa05032 | 0.41369592 |
| 160 | Allograft rejection_Homo sapiens_hsa05330 | 0.40450220 |
| 161 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39288266 |
| 162 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38712426 |
| 163 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38488300 |
| 164 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37442643 |
| 165 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37090008 |
| 166 | Circadian entrainment_Homo sapiens_hsa04713 | 0.36390421 |
| 167 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35135658 |
| 168 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.34116735 |
| 169 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.32823735 |
| 170 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.30574678 |
| 171 | Basal transcription factors_Homo sapiens_hsa03022 | 0.30027833 |
| 172 | Malaria_Homo sapiens_hsa05144 | 0.27309949 |
| 173 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26832625 |
| 174 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26715574 |
| 175 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.25673762 |
| 176 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.25323136 |
| 177 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24699952 |
| 178 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.23868563 |
| 179 | Cocaine addiction_Homo sapiens_hsa05030 | 0.23647156 |
| 180 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22288624 |
| 181 | Phototransduction_Homo sapiens_hsa04744 | 0.21643579 |
| 182 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.20812403 |
| 183 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.20581592 |
| 184 | Renin secretion_Homo sapiens_hsa04924 | 0.20417360 |
| 185 | Long-term depression_Homo sapiens_hsa04730 | 0.20237180 |
| 186 | Pertussis_Homo sapiens_hsa05133 | 0.19966267 |

